Mammography Jeopardy Practice Test

The main idea is that screening decisions for women in this age range should be made through open discussion with a clinician, with informed consent obtained before any screening proceeds. This reflects shared decision-making, recognizing that routine screening isn’t automatic for ages 30–44 and that a clear conversation about benefits, risks, and alternatives helps the patient decide what’s right for her. Informed consent means the patient understands what screening involves, including potential benefits and harms (such as false positives, anxiety, possible biopsies, and radiation exposure) and agrees to proceed. The other options don’t fit this approach: routine annual screening isn’t universally recommended for this age group, genetic testing isn’t indicated for everyone, and choosing no screening bypasses the essential discussion and consent step.